At this time, the standard of care for smoldering myeloma is still observational. For mild mds perhaps either just observe or blood transfusion
as needed and growth support therapy as indicated. For intermediate-high risk mds- hypomethylating agent like vidaza or other agent like Revlimid
) will be considered depending on the cytogenetics. F/u with your md.